drugset
drugset / Trial / NCT01380431

A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study

NCT01380431 ↗

Phase 1 Completed 18 enrolled Par Pharmaceutical, Inc. PharmaKinetics Laboratories Inc. · collab
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to compare the bioavailability of Par Lisinopril 40 mg Tablets and IPR Pharmaceuticals, Inc. Zestril (R).

Timeline

Start
1999-08
Primary completion
1999-10
Completion
1999-10

Drugs

EvaluationDrugModalityDoseRoute
Subject LISINOPRIL ANHYDROUS Small molecule 40 mg Oral

Indications

No indication recorded.